MRC-Holland MLPA. Description version 12; 02-12-2012



Similar documents
MRC-Holland MLPA. Related SALSA MLPA probemix P091 CFTR: contains probes for the CFTR gene, related to chronic pancreatitis.

MRC-Holland MLPA. Description version 24;

MRC-Holland MLPA. Description version 14;

Gene Mapping Techniques

Forensic DNA Testing Terminology

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

HiPer RT-PCR Teaching Kit

Data Analysis for Ion Torrent Sequencing

Becker Muscular Dystrophy

MUTATION, DNA REPAIR AND CANCER

How many of you have checked out the web site on protein-dna interactions?

Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company

Application Guide... 2

Introduction To Real Time Quantitative PCR (qpcr)

NATIONAL GENETICS REFERENCE LABORATORY (Manchester)

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

The NF1-gene a hotspot for de novo Alu- and L1-insertion?

DNA Sequence Analysis

Targeted. sequencing solutions. Accurate, scalable, fast TARGETED

Thermo Scientific DyNAmo cdna Synthesis Kit for qrt-pcr Technical Manual

PrimePCR Assay Validation Report

Biology Behind the Crime Scene Week 4: Lab #4 Genetics Exercise (Meiosis) and RFLP Analysis of DNA

European Medicines Agency

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

PrimePCR Assay Validation Report

Commonly Used STR Markers

Genolution Pharmaceuticals, Inc. Life Science and Molecular Diagnostic Products

restriction enzymes 350 Home R. Ward: Spring 2001

ab Hi-Fi cdna Synthesis Kit

Gene mutation and molecular medicine Chapter 15

Sequencing Guidelines Adapted from ABI BigDye Terminator v3.1 Cycle Sequencing Kit and Roswell Park Cancer Institute Core Laboratory website

Single-Cell Whole Genome Sequencing on the C1 System: a Performance Evaluation

Real-time PCR: Understanding C t

Biotechnology: DNA Technology & Genomics

2. True or False? The sequence of nucleotides in the human genome is 90.9% identical from one person to the next. False (it s 99.

Genetics Lecture Notes Lectures 1 2

Recombinant DNA & Genetic Engineering. Tools for Genetic Manipulation

Information leaflet. Centrum voor Medische Genetica. Version 1/ Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel

ID kit. imegen Anchovies II. and E. japonicus) DNA detection by. User manual. Anchovies species (E. encrasicolus. sequencing.

Design of conditional gene targeting vectors - a recombineering approach

How to construct transgenic mice

Genetics Module B, Anchor 3

360 Master Mix. , and a supplementary 360 GC Enhancer.

Introduction to next-generation sequencing data

Innovations in Molecular Epidemiology

BioBoot Camp Genetics

DNA Sequencing Handbook

FOR REFERENCE PURPOSES

Annex to the Accreditation Certificate D-PL according to DIN EN ISO/IEC 17025:2005

Idaho Technology Food Security Systems. System Components. Idaho Technology. Food Security and Pathogen Detection

Human Genome Organization: An Update. Genome Organization: An Update

SICKLE CELL ANEMIA & THE HEMOGLOBIN GENE TEACHER S GUIDE

Tools for human molecular diagnosis. Joris Vermeesch

Analysis of the DNA Methylation Patterns at the BRCA1 CpG Island

Bioinformatics Resources at a Glance

PrimeSTAR HS DNA Polymerase

ChIP TROUBLESHOOTING TIPS

Analysis of gene expression data. Ulf Leser and Philippe Thomas

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

Real-time quantitative RT -PCR (Taqman)

REAL TIME PCR USING SYBR GREEN

quantitative real-time PCR, grain, simplex DNA extraction: PGS0426 RT-PCR: PGS0494 & PGS0476

Molecular typing of VTEC: from PFGE to NGS-based phylogeny

2.500 Threshold e Threshold. Exponential phase. Cycle Number

AS Replaces Page 1 of 50 ATF. Software for. DNA Sequencing. Operators Manual. Assign-ATF is intended for Research Use Only (RUO):

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

Development of a Workflow to Detect Sequence Variants in the BRCA1 and BRCA2 Genes

Cancer Genomics: What Does It Mean for You?

The Power of Next-Generation Sequencing in Your Hands On the Path towards Diagnostics

Sanger Sequencing and Quality Assurance. Zbigniew Rudzki Department of Pathology University of Melbourne

Procedures For DNA Sequencing

Regents Biology REGENTS REVIEW: PROTEIN SYNTHESIS

PicoMaxx High Fidelity PCR System

When you install Mascot, it includes a copy of the Swiss-Prot protein database. However, it is almost certain that you and your colleagues will want

Multiplex your most important

qstar mirna qpcr Detection System

Reimbursement for Molecular Diagnostics

Breast cancer and the role of low penetrance alleles: a focus on ATM gene

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology

ncounter Gene Expression Assay Manual Total RNA and Cell Lysate Protocols

DNA Replication & Protein Synthesis. This isn t a baaaaaaaddd chapter!!!

50 g 650 L. *Average yields will vary depending upon a number of factors including type of phage, growth conditions used and developmental stage.

Welcome to Pacific Biosciences' Introduction to SMRTbell Template Preparation.

Intended Use: The kit is designed to detect the 5 different mutations found in Asian population using seven different primers.

Gene Expression Assays

Integrated Protein Services

Molecular Genetics: Challenges for Statistical Practice. J.K. Lindsey

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu

CCR Biology - Chapter 9 Practice Test - Summer 2012

Instructions. Torpedo sirna. Material. Important Guidelines. Specifications. Quality Control

DyNAmo cdna Synthesis Kit for qrt-pcr

The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".

LightCycler 480 Real-Time PCR System

Mir-X mirna First-Strand Synthesis Kit User Manual

Integrated Protein Services

RealStar HBV PCR Kit /2012

Transcription:

SALSA MLPA probemix P083-C1 CDH1 Lot C1-0211. As compared to previous B1 version, new in version C1: two CDH1 probes and several reference probes have been replaced/added. In addition, the 88 and 96nt control fragments have been replaced (QDX2). Germline mutations in the CDH1 gene have been reported in families with a hereditary predisposition to gastric cancer. CDH1 or E-cadherin is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein. Reduced expression of E-cadherin is regarded as one of the main molecular events involved in dysfunction of the cell-cell adhesion system, triggering cancer invasion and metastasis. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. The CDH1 gene (16 exons) spans ~98.2 kb of genomic DNA and is located on chromosome 16q22.1, ~67.4 Mb from the p-telomere. The P083-C1 probemix contains probes for each CDH1 exon. In addition, 17 reference probes are included in this probemix, detecting several different autosomal chromosomal locations. This SALSA probemix is designed to detect deletions/duplications of one or more sequences in the aforementioned gene in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by a single MLPA probe should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. We have no information on what percentage of defects in this gene is caused by deletions/duplications of complete exons. Finally, note that most defects in this gene are expected to be small (point) mutations, most of which will not be detected by this SALSA test. SALSA probemixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the SALSA test probemixes and reagents includes a limited license to use these products for research purposes. The use of a SALSA probemix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). References for SALSA probemix P083 CDH1 Oliveira C et al. (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Human Molecular Cancer 18:1545-55. More information Website : www.mlpa.com E-mail : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 6, 1057 DN Amsterdam, the Netherlands SALSA probemix P083 CDH1 Page 1 of 6

Data analysis The P083-C1 CDH1 probemix contains 34 MLPA probes with amplification products between 130 and 409 nt. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at 64-70-76-82 nt, three DNA denaturation control fragments (Dfragments) at 88-92-96 nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this probemix can first be normalised intra-sample by dividing the peak area of each probe s amplification product by the total area of only the reference probes in this probemix (block normalisation). Secondly, inter-sample normalisation can be achieved by dividing this intra-normalised probe ratio in a sample by the average intra-normalised probe ratio of all reference samples. Please note that this type of normalisation assumes no changes occurred in the genomic regions recognised by the reference probes. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exons deletions and amplifications can be done by e.g. Southern blotting, long range PCR, qpcr, FISH. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website www.mlpa.com. Many copy number alterations in healthy individuals are described in the database of genomic variants: http://projects.tcag.ca/variation. For example, a duplication of a complete gene might not be pathogenic, while a partial duplication or a deletion may result in disease. For some genes, certain in-frame deletions may result in a very mild, or no disease. Copy number changes of reference probes are unlikely to be the cause of the condition tested for. Users should always verify the latest scientific literature when interpreting their findings. This probemix was developed at. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA probemix P083 CDH1 Page 2 of 6

Table 1. SALSA MLPA P083-C1 CDH1 probemix Length (nt) SALSA MLPA probe Chromosomal position reference CDH1 64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 130 Reference probe 00797-L00463 5q31 137 * Reference probe 05659-L19935 2p22 142 * Reference probe 10699-L11281 6p12 148 CDH1 probe 12653-L19725 Exon 8 154 CDH1 probe 12651-L19938 Exon 1 160 CDH1 probe 02409-L19374 Exon 7 168 * Reference probe 05377-L06284 4p16 174 * CDH1 probe 16884-L19717 Exon 9 184 * Reference probe 09099-L09158 4q25 193 CDH1 probe 12654-L19369 Exon 2 202 CDH1 probe 02411-L01857 Exon 10 208 * Reference probe 11611-L12371 12p13 220 Reference probe 05939-L05368 1q22 229 CDH1 probe 02412-L01858 Exon 11 238 Reference probe 01670-L01250 11q22 247 * Reference probe 14971-L16707 6q22 258 CDH1 probe 02405-L19937 Exon 3 265 CDH1 probe 02413-L19371 Exon 13 273 * Reference probe 11541-L10062 3p25 283 CDH1 probe 02414-L01860 Exon 14 291 * Reference probe 08722-L08733 9q21 301 CDH1 probe 02407-L01853 Exon 5 310 * Reference probe 09065-L09234 19p13 316 CDH1 probe 02415-L19372 Exon 15 329 CDH1 probe 02408-L13240 Exon 6 337 CDH1 probe 02416-L01862 Exon 16 346 * Reference probe 06709-L06296 10p11 355 * Reference probe 10177-L06584 21q21 364 CDH1 probe 12656-L19936 Exon 4 373 Reference probe 04537-L03926 2q24 382 * CDH1 probe 16885-L19718 Exon 12 391 CDH1 probe 12657-L14803 Exon 2 400 * Reference probe 02460-L01904 15q21 409 * Reference probe 09821-L10231 10q26 * New in version C1 (from lot 0211 onwards). Changed in version C1 (from lot 0211 onwards): Small change in length, no change in sequence detected. Note: Exon numbering might be different as compared to literature! Please notify us of any mistakes. The identity of the genes detected by the reference probes is available on request: info@mlpa.com. SALSA probemix P083 CDH1 Page 3 of 6

Table 2. CDH1 probes arranged according to chromosomal location Length (nt) SALSA MLPA probe CDH1 exon Ligation site in NM_004360.3 Partial sequence (24 nt adjacent to ligation site) Distance to next probe start codon 125-127 (ex 1) 154 12651-L19938 Exon 1 140 nt after ex 1 AGCGGCCTGGAA-GCCTCGCGCGCT 0.3 kb 391 12657-L14803 Exon 2 369 nt before ex 2 CCGGGGATAAGA-AAGTGAGGTCGG 0.4 kb 193 12654-L19369 Exon 2 234-235 CGCCGAGAGCTA-CACGTTCACGGT 63.5 kb 258 02405-L19937 Exon 3 446-447 ACTCCACCTACA-GAAAGTTTTCCA 6.7 kb 364 12656-L19936 Exon 4 581-582 TCAGAAGACAGA-AGAGAGACTGGG 0.2 kb 301 02407-L01853 Exon 5 695-696 AGGTTTTCTACA-GCATCACTGGCC 1.5 kb 329 02408-L13240 Exon 6 844-845 TCCAACGGGAAT-GCAGTTGAGGAT 1.5 kb 160 02409-L19374 Exon 7 997-998 GACGCGGACGAT-GATGTGAACACC 0.4 kb 148 12653-L19725 Exon 8 1161-1162 CCTGGTGGTTCA-AGCTGCTGACCT 1.3 kb 174 * 16884-L19717 Exon 9 1422-1423 AGTGAACAACGA-TGGCATTTTGAA 2.2 kb 202 02411-L01857 Exon 10 1642-1643 CAGGAAATCACA-TCCTACACTGCC 3.7 kb 229 02412-L01858 Exon 11 1784-1785 GGGAGGATTTTG-AGCACGTGAAGA 2.8 kb 382 * 16885-L19718 Exon 12 2052-2053 CATTCAGTACAA-CGACCCAAGTGG 1.3 kb 265 02413-L19371 Exon 13 2166-2167 AGTGACCACCTT-AGAGGTCAGCGT 4.7 kb 283 02414-L01860 Exon 14 2318-2319 TGCTGTTTCTTC-GGAGGAGAGCGG 1.5 kb 316 02415-L19372 Exon 15 2479-2480 GTGACTCGTAAC-GACGTTGCACCA 3.7 kb 337 02416-L01862 Exon 16 2654-2655 CCGAAGCTGCTA-GTCTGAGCTCCC stop codon 2771-2773 (ex 16) * New in version C1 (from lot 0211 onwards). Changed in version C1 (from lot 0211 onwards): Small change in length, no change in sequence detected. The NM_004360.3 sequence is a reference standard in the NCBI RefSeqGene project. Note: Exon numbering might be different as compared to literature! Complete probe sequences are available on request: info@mlpa.com. Please notify us of any mistakes: info@mlpa.com. SALSA probemix P083 CDH1 Page 4 of 6

SALSA MLPA probemix P083-C1 CDH1 sample picture 70000 183.40 373.04 60000 50000 96.51 91.28 86.30 105.61 135.17 140.50 145.68 167.14 172.95 200.57 193.09 208.28 227.72 246.48 237.93 265.06 271.90 290.22 309.05 300.02 316.04 329.34 344.38 353.28 381.87 400.55 410.37 40000 128.26 152.53 159.73 220.34 336.84 391.70 282.63 364.72 30000 100.77 257.43 20000 D ye S ign al 10000 0 100 150 200 250 300 350 400 Size (nt) Figure 1. Capillary electrophoresis pattern of a sample of approximately 50 ng human male control DNA analysed with SALSA MLPA probemix P083-C1 CDH1 (lot 0211). The old MLPA buffer (replaced in December 2012) was used. Vials with the old MLPA buffer have a white label. 272.95 167.14 60000 172.96 200.55 227.71 50000 135.21 140.54 128.29 145.71 183.39 193.09 208.26 237.92 246.47 265.07 290.21 353.31 344.39 40000 30000 96.51 91.27 105.64 86.29 152.56 159.76 220.32 271.89 282.61 309.04 300.00 316.03 329.32 336.83 373.04 400.54410.36 391.71 381.88 364.73 20000 100.79 10000 257.43 D ye S ign al 0 100 150 200 250 300 350 400 Size (nt) Figure 2. Capillary electrophoresis pattern of a sample of approximately 50 ng human male control DNA analysed with SALSA MLPA probemix P083-C1 CDH1 (lot 0211). The new MLPA buffer (introduced in December 2012) was used. Vials with the new MLPA buffer have a yellow label. SALSA probemix P083 CDH1 Page 5 of 6

Implemented Changes compared to the previous product description versions Version 12 (48) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. Version 10 (48) - Remark on RefSeqGene standard added below Table 2. - Various minor textual changes. Version 10 (46) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). - Reference article has been added on page 1 - Various minor layout changes. Version 09 (46) - Warning added: SNP at ligation site of probe 02410-L01856. - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. - Data analysis method has been modified. - Various minor textual changes on page 1. - Various minor layout changes. SALSA probemix P083 CDH1 Page 6 of 6